Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dick Vet hospital hails FMT successes
Poppy was one of the animals treated with FMT at the hospital.
The hospital established a donor bank last year.

The Dick Vet Hospital for Small Animals has celebrated some of the pets successfully treated by its veterinary surgeons using faecal microbiota transplantation (FMT).

Last year, the hospital launched a donor bank to provide a reliable supply of faecal microbiota from healthy animals as it continues to use FMT to treat chronic and life-threatening gut problems in cats and dogs.

Two of the pets that have benefitted from the treatment are Poppy and Gilbert.

Poppy, an eight-year-old Labrador, was referred to the hospital with haemorrhagic gastroenteritis. Her serum proteins had dropped and she had severe stomach pain and bloody diarrhoea, loss of appetite, and was vomiting.

Common infections had already been ruled out, and after an ultrasound scan ruled out kidney and liver problems, she was giving a presumptive diagnosis of acute haemorrhagic diarrhoea syndrome. In addition to fluids and pain relief, the veterinary team gave her two FMTs over two days.

Following treatment, Poppy’s diarrhoea stopped, her serum protein levels were restored to normal, and she was able to be discharged
with easy-to-digest prescription food and probiotics.

Gilbert, a seven-month-old British shorthair cat, was referred to the hospital with severe chronic diarrhoea and faecal incontinence. While waiting for test results, he was given FMT by the veterinary team in an attempt to reset his gut microbiota.

Almost straight away his incontinence stopped. Test results then revealed that a parasitic infection was most likely causing his diarrhoea, for which he was treated. He was discharged, like Poppy, with easy-to-digest prescription food and probiotics.

Silke Salavati, head of Internal Medicine Service at the hospital, said: “We are delighted at the success we have had in both feline and canine patients following FMT treatment.

“We place the highest importance on screening our donor material to ensure that the highest quality of microbiota is available to the animals with severe gastrointestinal problems.”

Image © Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.